Back to editorials

Lead Opinion

World

France Is Right to Permit Assisted Dying

After years of debate, France's parliamentary approval of assisted dying for terminally ill adults under strict legal criteria recognizes a hard truth, that compassion without lawful access is only rhetoric, and caution has real human costs.

Portrait of Cassian Ro

By Cassian Ro / The Accelerator / 1153 words

Editorial illustration for "France Is Right to Permit Assisted Dying"

France has crossed an important threshold. After years of debate, Members of Parliament have approved legislation permitting assisted dying for terminally ill adults under strict legal criteria. That matters not only because of what it changes in law, but because of what it changes in moral posture. A modern state is finally admitting that preserving life at all costs is not always the same as honoring the person who must live, and die, inside that body.

The stakes should be defined plainly. This is not a general license to end life. It is not a casual relaxation of medical ethics. It is a narrowly bounded policy for terminally ill adults, with strict eligibility rules, passed only after extended public and parliamentary argument. The conflict is specific. Should French law force some dying patients to continue a final chapter they rationally, repeatedly, and lawfully wish to end, even when death is near and suffering is profound? Or should the law permit a supervised exit under strict criteria? On that question, France is right to permit it.

The strongest case for assisted dying begins with agency, but it does not end there. Autonomy matters because terminal illness collapses so many ordinary freedoms at once. Bodies fail, treatment options narrow, pain and dependence grow, and the horizon of recovery disappears. In that setting, a legal right to choose the manner and timing of one’s death is not some abstract libertarian flourish. It is a concrete preservation of personhood at the exact moment disease is stripping personhood away.

But the better argument, and the one too often evaded by opponents, is about the cost of delay. Every legal system that bans assisted dying tells the terminally ill the same thing: endure longer, even if your condition is irreversible; endure longer, even if your suffering is intolerable; endure longer, because the state is more comfortable with your pain than with your choice. That is not neutrality. It is a policy decision with victims. The harm of prohibition is not theoretical. It is measured in unwanted final days, forced deterioration, clandestine decisions, and families left to navigate desperation without a lawful framework.

Opponents raise serious concerns, and they deserve serious engagement. The most important objection is not theology or tradition, but vulnerability. Critics worry about coercion, subtle pressure, misdiagnosis, bureaucratic drift, and the possibility that a right presented as compassionate could become an expectation imposed on the weak. They warn that strict legal criteria may look robust on paper and then erode under social or institutional pressure. They are right to insist that words like dignity and choice cannot be allowed to conceal negligence, cost cutting, or abandonment.

That caution is valuable up to a point. It improves lawmaking. It forces precision. It demands auditability, medical review, and real safeguards. Yet caution becomes destructive when it asks for certainty that no serious area of medicine or law can provide. There is no zero risk regime in end of life care. Patients are already vulnerable under the status quo. Families are already under strain. Doctors already make grave judgments under uncertainty. The question is not whether risk exists. The question is whether risk is better managed through prohibition or through a transparent legal system with strict criteria. On that question, regulation is superior to denial.

This is where the French approach, as described, gets the architecture right. The law applies to terminally ill adults, not to everyone. It requires strict legal criteria, not vague appeals to suffering alone. It emerged after years of debate, not in a burst of legislative fashion. Those facts do not answer every implementation challenge, and supporters should not pretend they do. Eligibility definitions must be clear. Consent must be verified. Palliative care must remain robust. Oversight must be independent and credible. Narrow design is not a detail here, it is the condition of legitimacy.

Still, once those points are conceded, the anti-permission argument weakens substantially. If the law is confined to terminally ill adults, if strict criteria govern access, if the process is supervised rather than hidden, then the remaining objection is often less about practical safeguards than about symbolic discomfort. Some people fear that once the state permits assisted dying, it alters the moral meaning of medicine itself. Yet medicine already does more than preserve biological function. It relieves suffering, respects refusal, and recognizes limits. When cure is impossible and decline is certain, a supervised assisted death can fit within the same humane logic that underlies palliative medicine: not the conquest of death, but the refusal to turn dying into compulsory endurance.

There is also a broader civic point. Bad systems are not only cruel, they are brittle. A blanket ban does not eliminate demand for control at the end of life. It drives that demand underground, into isolation, desperate acts, or inequitable workarounds available mainly to the informed and well resourced. Lawful permission under strict criteria does the opposite. It brings an existing reality into the open, where doctors, judges, families, and regulators can see it, measure it, and correct it. Transparency is not moral decline. It is institutional adulthood.

Some defenders of the policy emphasize efficiency, including the possibility of avoiding prolonged futile care. That point should be handled carefully. Assisted dying must never be sold primarily as a budget tool. The case for this law is compassion and self-determination under strict safeguards, not cost trimming. But it is also unserious to deny that the status quo imposes enormous resource burdens on patients, families, and the healthcare system while often producing outcomes the patient does not want. Recognizing that reality is not cynical. It is part of honest policymaking.

The deeper issue is whether France will organize its end of life law around fear of misuse or around confidence in bounded human choice. Progress here does not mean indiscriminate expansion. It means building a legal pathway proportionate to a real and painful human need. The years of debate matter because they suggest the country did not stumble into this decision. Parliament confronted the moral gravity, tested the objections, and still concluded that for terminally ill adults under strict criteria, the law should permit assisted dying.

That is the right conclusion. A society that can extend life through science should also know when not to weaponize life extension against the wishes of the dying. Human flourishing is not served by maximizing duration at any price. Sometimes progress looks like more treatment, more time, more intervention. Sometimes it looks like the disciplined courage to let a competent adult say enough.

France should now do what mature democracies must do after a difficult but necessary reform. Implement carefully, report transparently, enforce strictly, and resist both panic and drift. The victory here is not death over life. It is mercy over compulsion, law over secrecy, and agency over enforced suffering. That is not a retreat from civilization. It is civilization behaving like it has learned something.